Regression and Stabilization of Coronary Vulnerable Plaque by Evolocumab as Assessed by Multidetector Row Computed Tomography.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Oct 2020
Historique:
pubmed: 3 7 2020
medline: 20 1 2021
entrez: 3 7 2020
Statut: ppublish

Résumé

A 65-year-old man was followed for his coronary conditions using 320-multi detector row computed tomography (MDCT) for 30 months. He had soft plaque in the right coronary artery (RCA) [mean density of plaque was 22 hounsfield units (HU)]. His initial serum low-density lipoprotein cholesterol (LDL-C) was 72 mg/dL. After 30 months, his serum LDL-C was 26 mg/dL under 5.0 mg/day rosuvastatin and evolocumab 140 mg/2 weeks. MDCT showed a regression of the plaque in the RCA and the plaque density was 114 HU (intermediate plaque). In conclusion, intensive lipid-lowering therapy with evolocumab induced the regression and stabilization of coronary vulnerable plaque.

Identifiants

pubmed: 32611955
doi: 10.2169/internalmedicine.4436-20
pmc: PMC7644491
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2391-2395

Références

Intern Med. 2007;46(12):859-63
pubmed: 17575379
J Am Coll Cardiol. 2010 Jun 15;55(24):2736-42
pubmed: 20538166
Circulation. 2004 Jul 20;110(3):265-70
pubmed: 15238460
Lancet. 2017 Oct 28;390(10106):1962-1971
pubmed: 28859947
JAMA. 2016 Dec 13;316(22):2373-2384
pubmed: 27846344
Circ J. 2009 Jan;73(1):132-8
pubmed: 19039190
J Am Coll Cardiol. 2015 Aug 4;66(5):495-507
pubmed: 26227186
Circulation. 2000 Feb 15;101(6):598-603
pubmed: 10673250
Circulation. 2004 Jan 6;109(1):14-7
pubmed: 14691045
Atherosclerosis. 2010 Jun;210(2):497-502
pubmed: 20036363
J Am Coll Cardiol. 2009 Jul 21;54(4):293-302
pubmed: 19608026
J Am Coll Cardiol. 2001 Apr;37(5):1430-5
pubmed: 11300457
N Engl J Med. 2005 Apr 7;352(14):1425-35
pubmed: 15755765
Circ J. 2010 Jun;74(6):1165-74
pubmed: 20467151
AJR Am J Roentgenol. 2006 Aug;187(2):W241
pubmed: 16861524
Circulation. 2005 Jul 26;112(4):598-617
pubmed: 16046290
Circulation. 2004 Aug 31;110(9):1061-8
pubmed: 15326073
Atherosclerosis. 2005 May;180(1):1-10
pubmed: 15823269
Am J Manag Care. 2012 Apr;18(4):193-9
pubmed: 22554007

Auteurs

Yuhei Shiga (Y)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Yoshiaki Idemoto (Y)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Kohei Tashiro (K)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Tomoki Imaizumi (T)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Yoko Ueda (Y)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Yuiko Yano (Y)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Kenji Norimatsu (K)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Ayumi Nakamura (A)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Shin-Ichiro Miura (SI)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH